NCT01764048

Brief Summary

Cesarean deliveries are prevalent. Unlike other operations, quick recovery is required for the mother to nurture the newborn child and establishing an appropriate mother-child bonding. Therefore, effective pain management is crucial. In this study we would like to compare between two pain relievers' administration protocols: (1) pain relievers' administration in fix protocol (type of medications, dose and intervals) or (2) pain relievers' administration following demand (the same type and doses, however, medications will be given only following patient's request). The primary outcome will be patient satisfaction, pain control and the necessity of additional medications (rescue doses). The protocols will be used for the first 48 hours following surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
214

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2012

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2012

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 2, 2013

Completed
7 days until next milestone

First Posted

Study publicly available on registry

January 9, 2013

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2014

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2014

Completed
Last Updated

January 8, 2016

Status Verified

January 1, 2016

Enrollment Period

1.2 years

First QC Date

January 2, 2013

Last Update Submit

January 7, 2016

Conditions

Keywords

pain managementcesarean section

Outcome Measures

Primary Outcomes (1)

  • The efficacy of pain management

    Pain sensation will be assessed using the VAS scale (visual analog scale) for measurement of acute pain

    during 48 hours from surgery

Secondary Outcomes (5)

  • adverse effect of the medications given in each protocol

    during 48 hours following surgery

  • to compare the amount of breastfeeding between 2 groups

    following the week after surgery

  • The number of times that pain medications were given in each study group

    during 48 hours following surgery

  • The necessity of additional medications (rescue doses)

    During 48 hours after surgery

  • Patient satisfaction

    48 hours after surgery

Study Arms (2)

Fix protocol

EXPERIMENTAL

During 48 hours following surgery pain medications will be given as followed (listed in brackets are the generic names of each medication): At patient arrival to the department: Intravenous Tramadol hydrochloride 100 milligrams + TAB. Paracetamol 500 milligrams + TAB. Diclofenac 100 milligrams After 6 hours from patient arrival and every 6 hours: TAB. Zaldiar (Paracetamol 650 milligrams + Tramadol 75 milligrams). After 12, 24 and 48 hours from patient arrival: TAB. Diclofenac 100 milligrams. Rescue medication: TAB. Percocet (Oxycodone 5MG/Paracetamol 325 MG)as necessary up to 4 times per day. The total amount of paracetamol is limited to 4 gr per day.

Drug: Fix protocol

medications following demand protocol

EXPERIMENTAL

The same combinations will be given as in the fixed protocol however only after patient request

Drug: medications following demand protocol

Interventions

Please see arm description

Fix protocol

Please see arm description

medications following demand protocol

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • women that underwent cesarean section

You may not qualify if:

  • Women suffering from chronic pain
  • Women using chronic pain medications
  • Allergy to any drug used in the study
  • Women underwent general anesthesia during the surgery
  • women with elevated liver enzymes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Departement of obstetric and gynecology, HaEmek medical center

Afula, 18101, Israel

Location

MeSH Terms

Conditions

Agnosia

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 2, 2013

First Posted

January 9, 2013

Study Start

November 1, 2012

Primary Completion

January 1, 2014

Study Completion

June 1, 2014

Last Updated

January 8, 2016

Record last verified: 2016-01

Locations